🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

344 results for “AVI” Clear

  1. Olanzapine

    United Therapeutics Europe Ltd

    Acute Agitation, Behavioural Emergency

    approved small molecule terminated

    1 trial

  2. Plavix 75 mg film-coated tablets, CARDIOASPIRIN 100 mg Compresse gastroresistenti, CARDIOASPIRIN 100 mg Compresse gastroresistenti, Plavix 300 mg film-coated tablets

    Fondazione Telethon ETS

    Patients with atrial fibrillation undergoing percutaneous left atrial appendage closure with the Amulet device

    approved small molecule active

    1 trial

  3. Plavix 75 mg film-coated tablets, Clopidogrel Viatris 75 mg film-coated tablets, ACETYLSALICYLIC ACID , DIPYRIDAMOLE

    Disc Medicine

    Stroke

    approved small molecule active

    1 trial

  4. ROCTAVIAN 2 × 1013 vector genomes/mL solution for infusion

    BioMarin Pharmaceutical Australia Pty Ltd

    Hemophilia A

    approved small molecule active

    1 trial

  5. Raltegravir

    Merck KGaA, Darmstadt, Germany

    Human Immunodeficiency Virus (HIV) Infection

    approved small molecule completed

    1 trial

  6. Rescue Intravitreal Aflibercept Injection

    Regeneron UK Limited

    Neovascular Polypoidal Choroidal Vasculopathy

    approved small molecule active

    1 trial

  7. Sodium Chloride 0.9%, Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial

  8. Sodium Oxybate

    Jazz Pharmaceuticals Ireland Limited

    REM Sleep Behavior Disorder

    approved small molecule completed

    1 trial

  9. TACROLIMUS, SIROLIMUS, MYCOPHENOLATE MOFETIL, AZATHIOPRINE, PREDNISOLONE, EVEROLIMUS, MYCOPHENOLIC ACID, BELATACEPT, CICLOSPORIN

    The George Institute

    BK Polyomavirus DNAemia after kidney transplantation

    approved small molecule active

    1 trial

  10. Vyvgart 20 mg/mL concentrate for solution for infusion

    The George Institute

    Patients affected by generalized myasthenia gravis

    approved small molecule active

    1 trial

  11. Zavicefta, Ceftazidime-Avibactam

    Pfizer

    Hospital-Acquired Pneumonia

    approved small molecule completed

    1 trial

  12. Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZ 300 mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  13. entecavir

    The First People's Hospital of Lianyungang

    Liver Fibrosis

    approved small molecule completed

    1 trial

  14. oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  15. pegylated interferon alpha and plus ribavirin

    Hospital Authority, Hong Kong

    Chronic Hepatitis C

    approved small molecule completed

    1 trial

  16. treatment with CAZ-AVI

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Patients With Critically Ill Infections

    approved small molecule active

    1 trial

  17. ASC09/ritonavir group

    The First People's Hospital of Lianyungang

    2019-nCoV

    small molecule terminated

    1 trial

  18. CocoaVia supplement

    United Therapeutics Europe Ltd

    Cold Exposure

    other active

    1 trial

  19. Cognitive behavioral therapy for anxiety plus benzodiazepine taper

    BRIGHT MINDS BIOSCIENCES INC.

    Anxiety Disorders

    other completed

    1 trial

  20. Compound Norethisterone Enanthate Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Contraception Behavior

    small molecule active

    1 trial

  21. Efgartigimod + Telitacicept (1-week interval) group

    The First People's Hospital of Lianyungang

    Myasthenia Gravis

    small molecule active

    1 trial

  22. Entecavir

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma

    small molecule completed

    1 trial

  23. Entecavir 0.5 mg

    The First People's Hospital of Lianyungang

    Hepatitis B

    small molecule active

    1 trial

  24. Evaluation of social, cultural and behavioral factors

    International Peace Maternity and Child Health Hospital

    Cardio-vascular Disease

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources